Norges Bank
STOK icon

Norges Bank’s Stoke Therapeutics STOK Stock Holding History

Norges Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Buy
+163,200
New +$5.24M ﹤0.01% 1379
2025
Q1 		– Sell
-314,800
Closed -$3.47M – 1843
2024
Q4 		$3.47M Buy
+314,800
New +$3.87M ﹤0.01% 1590
2024
Q2 		– Sell
-50,000
Closed -$675K – 1982
2024
Q1 		$675K Buy
+50,000
New +$303K ﹤0.01% 1822
2023
Q3 		– Sell
-24,700
Closed -$263K – 2028
2023
Q2 		$263K Buy
+24,700
New +$263K ﹤0.01% 1989
2023
Q1 		– Sell
-394,312
Closed -$3.64M – 2161
2022
Q4 		$3.64M Buy
394,312
+199,900
+103% +$2.08M ﹤0.01% 1868
2022
Q3 		$2.5M Hold
194,412
– – ﹤0.01% 1878
2022
Q2 		$2.57M Buy
194,412
+48,812
+34% +$742K ﹤0.01% 1867
2022
Q1 		$3.06M Buy
+145,600
New +$2.92M ﹤0.01% 1931
2021
Q4 		– Sell
-45,200
Closed -$1.15M – 2287
2021
Q3 		$1.15M Buy
+45,200
New +$1.26M ﹤0.01% 2132
2019
Q4 		– Sell
-25,000
Closed -$537K – 2093
2019
Q3 		$537K Hold
25,000
– – ﹤0.01% 2059
2019
Q2 		$729K Buy
+25,000
New +$671K ﹤0.01% 2048

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank's STOK Position: Q2 2026 in Review

Norges Bank opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 163,200 shares worth $5.34M. The stake represents ﹤0.01% of the portfolio and ranks #1379 among its holdings. This is a return to the name: Norges Bank previously reported a position in STOK as recently as Q4 2024.

Norges Bank first reported a position in STOK in Q2 2019 and has held it in 11 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Norges Bank held 163,200 shares of Stoke Therapeutics worth $5.34M as of Q2 2026.
  • Stoke Therapeutics was a new Norges Bank position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1379 holding.
  • Norges Bank first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 11 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.